Prot #GR40550/RO4893594: A Phase III, Multicenter, Randomized Visual Assesor-Masked, Active-Comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System with Ranibizumab in Patients with Diabetic Macular Edema (PAGODA)

Project: Research project

Project Details

StatusActive
Effective start/end date3/13/20 → 3/13/26

Funding

  • Genentech, Inc ((OE) Prot #GR40550/RO4893594)